Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-18-001105
Filing Date
2018-04-27
Accepted
2018-04-27 15:04:39
Documents
41
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K proteo_10k-123117.htm 10-K 449120
2 LIST OF SUBSIDIARIES proteo_10k-ex2100.htm EX-21 1017
3 CERTIFICATION proteo_10k-ex3101.htm EX-31.1 7792
4 CERTIFICATION proteo_10k-ex3102.htm EX-31.2 7780
5 CERTIFICATION proteo_10k-ex3200.htm EX-32 4126
  Complete submission text file 0001683168-18-001105.txt   1720350

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE pteo-20171231.xml EX-101.INS 205729
7 XBRL SCHEMA FILE pteo-20171231.xsd EX-101.SCH 14690
8 XBRL CALCULATION FILE pteo-20171231_cal.xml EX-101.CAL 34052
9 XBRL DEFINITION FILE pteo-20171231_def.xml EX-101.DEF 54709
10 XBRL LABEL FILE pteo-20171231_lab.xml EX-101.LAB 136406
11 XBRL PRESENTATION FILE pteo-20171231_pre.xml EX-101.PRE 108511
Mailing Address 2102 BUSINESS CENTER DRIVE IRVINE CA 92612
Business Address 2102 BUSINESS CENTER DRIVE IRVINE CA 92612 949-253-4616
PROTEO INC (Filer) CIK: 0001063104 (see all company filings)

EIN.: 880292249 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30728 | Film No.: 18783218
SIC: 2834 Pharmaceutical Preparations